Article

Efficacy and Safety of AYUSH-64 in COVID-19: A Systematic Review and Meta-Analysis

2022-03-04

Abstract excerpt

Objective: To critically appraise the evidence from randomized controlled trials (RCTs) on efficacy and safety of AYUSH-64 in the management of COVID-19.<br><br>Methods: The systematic review was conducted according to the PRISMA guidelines. AYUSH Research Portal, PubMed, DHARA, Cochrane CENTRAL, COVID-19 Evidence Alerts, Epistemonikos, TRIP database, NCCMT database of COVID-19 studies and Google Scholar were sear...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 04f4db31-441c-5d0c-9ae4-076369ec33f7
DOI: 10.2139/ssrn.4049618

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy and Safety of AYUSH-64 in COVID-19: A Systematic Review and Meta-AnalysisDOI 10.2139/ssrn.4049618Read

Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trialSemantic proximity Read

Application of observational research methods to real-world studies for rare disease drugs: a scoping review protocolSemantic proximity Read

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read

Effect of Paxlovid Treatment During Acute Covid-19 on Long Covid Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER ConsortiaSemantic proximity Read

Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysisSemantic proximity Read

The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses InfectionSemantic proximity Read

REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 OutpatientsSemantic proximity Read

Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19Semantic proximity Read

Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

Long COVID Treatment No Silver Bullets, Only a Few Bronze BBsSemantic proximity Read

Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trialSemantic proximity Read

Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platformSemantic proximity Read